Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(36 Publications)
Rabbit Recombinant Monoclonal Serine/threonine-protein kinase 4/MST-1 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human, Rat, Mouse samples. Cited in 36 publications.
View Alternative Names
KRS2, MST1, STK4, Serine/threonine-protein kinase 4, Mammalian STE20-like protein kinase 1, STE20-like kinase MST1, Serine/threonine-protein kinase Krs-2, MST-1
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y] (AB51134)
Intracellular Flow Cytometry analysis of HeLa cells labelling Serine/theronine-protein kinase 4/MST-1 with purified ab51134 at a dilution of 1/50 (red). Cells were fixed with 4% paraformaldehyde and permeabilized with 90% methanol. An Alexa Flour® 488-conjugated goat anti-rabbit IgG (1/2000) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y] (AB51134)
ab51134 staining Serine/threonine-protein kinase 4/MST-1 in human gastric carcinoma tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with paraformaldehyde and antigen retrieval was by heat mediation in a EDTA buffer. Samples were incubated with primary antibody at a dilution of 1/50. A goat anti-rabbit IgG H&L (HRP) ab97051 was used as the secondary antibody at a dilution of 1/500.
Negative control 1 : PBS in place of primary antibody.
- IP
Unknown
Immunoprecipitation - Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y] (AB51134)
ab51134 immunoprecipitating Serine/threonine-protein kinase 4/MST-1. 10μg of cell lysate was incubated with primary antibody at a dilution of 1/30 and VeriBlot for IP Detection Reagent (HRP) (ab131366) at a dilution of 1/1000.
Lane 1 : Jurkat (human acute T cell leukemia) whole cell lysate (10ug)
Lane 2 : Jurkat (human acute T cell leukemia) whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab51134 in Jurkat (human acute T cell leukemia) whole cell lysate
All lanes:
Immunoprecipitation - Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y] (ab51134)
Predicted band size: 55 kDa
false
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y] (AB51134)
ab51134 staining Serine/threonine-protein kinase 4/MST-1 in Raw264.7 (mouse abelson murine leukemia virus-induced tumor) cells by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with 100% methanol and permeabilized with 0.1% Triton X-100. Samples were incubated with primary antibody at a dilution of 1/100. A goat anti rabbit IgG (Alexa Fluor® 488) (ab150077) was used as the secondary antibody at a concentration of 1/1000. ab7291 anti-Tubulin (mouse mAb) (1/1000) and ab150120 AlexaFluor®594 Goat anti-Mouse secondary (1/1000) were used as counterstains for primary antibody ab51134 and secondary antibody ab150077 respectively and DAPI was used as a nuclear counterstain.
Negative control 1 : Rabbit primary antibody and anti-mouse secondary antibody (ab150120)
Negative control 2 : Mouse primary antibody (ab7291) and anti-rabbit secondary antibody (ab150077)
- WB
Unknown
Western blot - Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y] (AB51134)
Lanes 1-4 : Merged signal (red and green). Green - ab51134 observed at 52 kDa. Red - loading control ab8245 observed at 37 kDa.
ab51134 Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y] was shown to specifically react with MST-1 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265442 (knockout cell lysate ab258215) was used. Wild-type and MST-1 knockout samples were subjected to SDS-PAGE. ab51134 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y] (ab51134) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
STK4 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human STK4 (Serine/threonine-protein kinase 4/MST-1) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-stk4-serine-threonine-protein-kinase-4-mst-1-knockout-hela-cell-line-ab265442'>ab265442</a>)
Lane 3:
Jurkat cell lysate at 20 µg
Lane 4:
Ramos cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution
Predicted band size: 55 kDa
Observed band size: 52 kDa
false
- WB
Lab
Western blot - Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y] (AB51134)
Diluting and blocking buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y] (ab51134) at 1/50000 dilution
Lane 1:
Jurkat (human acute T cell leukemia) whole cell lysate at 1/20 dilution
Lane 2:
Mouse spleen at 1/20 dilution
Lane 3:
Rat spleen at 1/20 dilution
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/2000 dilution
Predicted band size: 55 kDa
false
- WB
Lab
Western blot - Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y] (AB51134)
Diluting and blocking buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y] (ab51134) at 1/10000 dilution
All lanes:
HeLa (human cervix adenocarcinoma) whole cell lysate at 20 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/2000 dilution
Predicted band size: 55 kDa
false
Related conjugates and formulations (8)
-
Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y] - BSA and Azide free
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y]
-
578 PE
PE Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y]
-
660 APC
APC Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-Serine/threonine-protein kinase 4/MST-1 antibody [EP1465Y]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This kinase orchestrates various cellular processes mainly through regulation of apoptosis and cell stress responses. MST-1 interacts with other signaling molecules in cells forming part of larger multi-protein complexes. These interactions allow MST-1 to act as a molecular switch effectively controlling the balance between cell survival and death. The cellular localization and interaction partners help diversify its biological roles.
Pathways
MST-1 predominantly influences the Hippo signaling pathway—a pathway significant in controlling organ size and suppressing cancer. In this pathway MST-1 phosphorylates and activates LATS1/2 kinases creating an endpoint effect on cell proliferation and apoptosis. MST-1 also participates in the oxidative stress response pathway where it shows interaction with FoxO transcription factors leading to modifications in gene expression profiles.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (36)
Recent publications for all applications. Explore the full list and refine your search
Science advances 11:eadr7208 PubMed40203118
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biomedical science 31:100 PubMed39497128
2024
Applications
Unspecified application
Species
Unspecified reactive species
Helicobacter 29:e13109 PubMed38951739
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 20:1004-1023 PubMed38250155
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 51:10568-10589 PubMed37739411
2023
Applications
Unspecified application
Species
Unspecified reactive species
World journal of stem cells 15:90-104 PubMed37007455
2023
Applications
Unspecified application
Species
Unspecified reactive species
Discover. Oncology 14:17 PubMed36735162
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 13:993788 PubMed36263059
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2022:3458283 PubMed35656021
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2022:9974639 PubMed35308166
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com